BCR-ABL transcript analysis of patients (pts) with imatinib-resistant or -intolerant chronic myeloid leukemia in chronic phase (CML-CP) treated with nilotinib.

被引：0

作者：

Kim, D.

Saglio, G.

Martinelli, G.

Shou, Y.

Stein, A. M.

Woodman, R. C.

Kantarjian, H.

Hughes, T. P.

Radich, J. P.

Hochhaus, A.

机构：

[1] Catholic Univ Korea, Seoul St Marys Hosp, Seoul, South Korea

[2] Univ Turin, San Luigi Gonzaga Hosp, Orbassano, Italy

[3] Inst Hematol, Bologna, Italy

[4] Novartis Inst BioMed Res, Cambridge, MA USA

[5] Novartis Pharmaceut, Cambridge, MA USA

[6] Novartis Pharmaceut, E Hanover, NJ USA

[7] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA

[8] SA Pathol, Dept Haematol, Adelaide, SA, Australia

[9] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA

[10] Univ Klinikum Jena, Jena, Germany

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 15期

关键词：

D O I：

10.1200/jco.2010.28.15_suppl.6567

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

6567

引用

页数：1

共 50 条

[41] Efficacy and Safety of Nilotinib in elderly patients with Chronic Myeloid Leukemia in Chronic Phase (CML-CP) with Imatinib Resistance or Intolerance [J].

Ottmann, O. G. ;

le Coutre, P. ;

Gattermann, N. ;

Hochhaus, A. ;

Bruemmendorf, T. H. ;

Kindler, T. ;

Duyster, J. ;

Al-Ali, H. ;

Lipton, J. ;

Wang, J. ;

Yang, M. ;

Szczudlo, T. ;

Giles, F. .

ONKOLOGIE, 2010, 33 :138-138

[42] BCR-ABL Fluctuation Analysis in Chronic Phase Chronic Myeloid Leukemia (CP-CML) Patients with MR 4.5 [J].

Pereira, Mariana Pinto ;

Vanelli, Tito ;

da Silva, Eduardo Gomes ;

Americo, Andre Dias ;

Burin, Mariana M. ;

Soares, Tahiane ;

Silla, Lucia ;

Daudt, Liane ;

Fogliatto, Laura .

BLOOD, 2015, 126 (23)

[43] A phase II study of nilotinib administered to imatinib resistant and intolerant patients with chronic myelogenous leukemia (CML) in chronic phase (CP) [J].

Rosti, G. ;

le Coutre, P. ;

Bhalla, K. ;

Giles, F. ;

Ossenkoppele, G. ;

Hochhaus, A. ;

Gattermann, N. ;

Haque, A. ;

Weitzman, A. ;

Baccarani, M. ;

Kantarjian, H. .

JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)

[44] Efficacy and Safety of Nilotinib in Elderly Patients with Imatinib-Resistant or -Intolerant Chronic Myeloid Leukemia (CML) in Chronic Phase (CP): A Sub-Analysis of the ENACT (Expanding Nilotinib Access in Clinical Trials) Study [J].

le Coutre, Philipp D. ;

Turkina, Anna ;

Kim, Dong-Wook ;

Ceglarek, Bernadeta ;

Alimena, Giuliana ;

Al-Ali, Haifa Kathrin ;

Shen, Zhixiang ;

Jootar, Saengsuree ;

Smith, Graeme ;

De Souza, Carmino Antonio ;

Dorlhiac-Llacer, Pedro Enrique ;

Rizzieri, David A. ;

Szczudlo, Tomasz ;

Berton, Myriam ;

Wang, Jim ;

Wang, Si-Tien ;

Nicolini, Franck Emmanuel .

BLOOD, 2009, 114 (22) :1272-1273

[45] Patients (Pts) with Ph plus Chronic, Myeloid Leukemia In Chronic Phase (CML-CP) with a Suboptimal Molecular Response to Imatinib (IM) Can Achieve Deeper Responses When Switched to Nilotinib. [J].

Miller, Carole ;

Ailawadhi, Sikander ;

Jillella, Anand P. ;

Radich, Jerald P. ;

DeAngelo, Daniel J. ;

Goldberg, Stuart L. ;

Williams, Denise ;

Lin, Felice P. ;

Akard, Luke Paul .

BLOOD, 2010, 116 (21) :950-950

[46] Incidence of Hyperglycemia by 3 Years in Patients (Pts) with Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase (CML-CP) Treated with Nilotinib (NIL) or Imatinib (IM) in ENESTnd [J].

Delphine, Rea ;

Gautier, Jean-francois ;

Breccia, Massimo ;

Saglio, Giuseppe ;

Hughes, Timothy P. ;

Kantarjian, Hagop M. ;

Kemp, Charisse ;

Gao, Haitao ;

Piccolo, Carmen ;

Larson, Richard A. ;

Hochhaus, Andreas .

BLOOD, 2012, 120 (21)

[47] Detection of BCR-ABL point mutations in patients with chronic myeloid leukemia (CML) resistant to imatinib. [J].

Silveira, Rosana A. ;

Albuquerque, Dulcineia M. ;

Assis, Angela M. ;

Ichihara, Edson ;

de Souza, Carmino A. ;

Costa, Fernando F. ;

Delamain, Marcia T. ;

Vigorito, Afonso C. ;

Lorand-Metze, Irene ;

Miranda, Eliana ;

Pagnano, Katia B. B. .

BLOOD, 2006, 108 (11) :289B-289B

[48] Increase of BCR-ABL/ABL Ratio That Corresponds to BCR-ABL Mutation Detection In Chronic Myeloid Leukemia (CML) Patients Treated by Imatinib (IM) [J].

Tsaur, Grigory ;

Popov, Alexander ;

Ivanova, Anna ;

Yakovleva, Yulia ;

Riger, Tatyana ;

Plekhanova, Olga ;

Ivanets, Yulia ;

Shorikov, Egor ;

Saveliev, Leonid ;

Fechina, Larisa .

FASEB JOURNAL, 2011, 25

[49] Pharmacokinetics of nilotinib in imatinib-resistant/intolerant chronic myeloid leukemia patients on hemodialysis for chronic renal failure [J].

Onaka, Takashi ;

Takahashi, Naoto ;

Miura, Masatomo ;

Yonezawa, Akihito ;

Imada, Kazunori ;

Sawada, Kenichi .

AMERICAN JOURNAL OF HEMATOLOGY, 2012, 87 (04) :451-451

[50] Glucose Metabolism (GM) Changes in Nondiabetic Patients (Pts) With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase (CML-CP) Treated With Nilotinib (NIL) or Imatinib (IM) [J].

Gautier, Jean-Francois ;

Rea, Delphine ;

Saglio, Giuseppe ;

Hughes, Timothy P. ;

Kantarjian, Hagop M. ;

Kemp, Charisse ;

Gao, Haitao ;

Piccolo, Carmela ;

Larson, Richard A. ;

Hochhaus, Andreas ;

Breccia, Massimo .

DIABETES, 2013, 62 :A704-A705

← 1 2 3 4 5 →